Atenolol use after noncardiac surgery in cardiac patients
- Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats. Goyal, Ramesh K.; Bhadada, Shraddha V. // Canadian Journal of Physiology & Pharmacology;Aug2007, Vol. 85 Issue 8, p831
Recently, various clinical studies have indicated that lipophilic �-blockers reduce the coronary mortality in diabetic patients; however, systematic studies have not been reported. The objective of the present investigation was to compare the effects of chronic treatment with metoprolol and...
- Would a polypill be beneficial in UK practice? McCormack, Terry // GP: General Practitioner;6/12/2009, p30
In this article the author discusses a debate about the potential of a polypill in reducing cardiovascular risk. The author notes that the polypill has varied on some ingredients as beneficial to reduce cardiovascular risk, but includes 12.5mg hydrochlorothiazide, 50mg atenolol, 5mg ramipril,...
- Drug cuts death rates after surgery in half. Ferraro, Julia // RN;Apr97, Vol. 60 Issue 4, p17
Presents the results of a study on the effect of atenolol on patients' mortality after noncardiac surgery. Death rate of patients who took atenolol after a noncardiac surgery; Conclusion on the advantage of atenolol.
- Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. Deacon, S.P.; Karunanayake, A.; Barnett, D. // British Medical Journal;11/12/1977, Vol. 2 Issue 6097, p1255
Examines the metabolic effects of propranolol, acebutolol and atenolol on diabetics. Effects of the drugs; Therapeutic uses of the drugs; Safety of the drugs over pro-selective drugs in treating patients with diabetes.
- Comparison of atenolol and propranolol during insulin-induced hypoglycaemia. Deacon, S.P.; Barnett, D. // British Medical Journal;7/31/1976, Vol. 2 Issue 6030, p272
Investigates the use of atenolol during insulin-induced hypoglycaemia. Effects of atenolol on pulse rate, sweating and blood glucose levels; Comparison of atenolol with propranolol; Safety of atenolol for use in patients receiving insulin.
- Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Day, J.L.; Simpson, N.; Metcalfe, J.; Page, R.L. // British Medical Journal;1/13/1979, Vol. 1 Issue 6156, p77
Examines the metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Observation on the increase of basal plasma triglyceride concentration; Description on the changes in triglyceride concentration; Decrease of basal free fatty acid concentrations.
- Atenolol and bendrofluazide in hypertension. Petrie, J.C.; Galloway, D.B.; Webster, J.; Simpson, W.T.; Lewis, J.A. // British Medical Journal;10/18/1975, Vol. 4 Issue 5989, p133
Examines the efficacy of atenolol and bendrofluazide in treating hypertension. Reduction in all blood pressure levels; Absence of significant postural or postexercise hypotension; Effect of the drug on the hematological or biochemical indices.
- Rx for deaths after surgery. Podolsky, Doug; Beddingfield, Katherine T. // U.S. News & World Report;12/16/96, Vol. 121 Issue 24, p75
Discusses the benefits of administering atenolol during hospitalization following heart surgery. The reduction of risk of death for up to two years following the operation; The report by Dennis Mangano in `The New England Journal of Medicine.'
- Losartan was more effective than atenolol for isolated systolic hypertension and left ventricular hypertrophy. Rembold, Christopher M. // ACP Journal Club;Mar/Apr2003, Vol. 138 Issue 2, p37
Compares the effectiveness of losartan-based with atenolol-based therapy in patients with isolated systolic hypertension and left ventricular hypertrophy. Description of the patients in the study; Goal of antihypertensive therapy; Details of the study conducted by the Medical Research Council...